Tumor markers and lung cancer: Guidelines in a cost-limited medical organization

International Journal of Biological Markers

Volumn 11, Issue 2, 1996, Pages 61-66

  Falcone, F ^a   Marinelli, M ^b   Minguzzi, L ^b   Paganelli, G M ^a   Turba, E ^b   Cavalli, A ^a   Rapellino, M ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

CEA; Diagnosis related groups; Lung cancer; Pleural effusions; Tumor markers

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG CANCER; MALE; PLEURA EFFUSION; REIMBURSEMENT;

EID: 0029970156     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089601100201     Document Type: Article

References (8)

1. Prodi G. Il problema dei marcatori tumorali. Quaderni di Ligand Quarterly 1984; 4: 13-27.
2. Comitato Nazionale per lo Studio dei Marcatori Tumorali, Società Italiana di Prevenzione, Diagnosi e Terapia dei Tumori (SIPDTT). I marcatori tumorali nella pratica clinica: classificazione, metodi di misura, applicazione e interpretazione dei risultati. Acta Oncologica 1993; 14: 5-41.
3. Fetter RB, ed. The new ICD-9 diagnosis related groups classification scheme. Users' manual. Health System Management Group, Yale University, New Haven 1981, vol. 1.
4. Fetter RB, Mills RE, Riedel DC, Thompson JD. The application of diagnostic specific profiles to cost and reimbursement control in hospitals. J Med Syst 1977; 1-137.
5. Gay EG, Kronenfeld JJ: Regulation, retrenchement. The DRG reimbursement practice. Soc Sci Med 1990; 31: 1013-18.
6. Falcone F, Sabbatani S, Magri P, Fini A, Faraca M: La diagnosi delle pleuriti neoplastiche: significato del CEA. In: Corrado F, Maltoni C, Ferri C, Paladini G, Buraggi GL, Carretti D, eds. I markers tumorali. Bologna: Monduzzi 1986, 417-21.
7. Bates SE, Longo DL: Use of serum tumor markers in cancer diagnosis and management. Semin Oncol 1987; 14: 102-9.
8. Sandler RS, Freund DA, Herbst CA, et al.: Cost effectiveness of postoperative carcinoembryonic antigen in monitoring colorectal cancer. Cancer 1984; 53: 193-6.